 |
|
|
|
|
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shiro Ohki has been an auditor of Oncolys BioPharma Inc. since 2007. He is also a director of R&D division of Fuji Chemical Industry Co. Ltd. Prior to that, he worked for Japan Tobacco (JT) and Ono Pharmaceutical Co. Ltd., especially in the area of clinical development. Mr. Ohki received his Ph.D. in Pharmacology from Kyoto University. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright
(c)2004-2005, Oncolys BioPharma Inc. All rights reserved.
|
|
